Your browser doesn't support javascript.
loading
The association between survivin −31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population
J Cancer Res Ther ; 2019 Jan; 15(1): 82-86
Article | IMSEAR | ID: sea-213433
ABSTRACT

Background:

The case–control study aimed to investigate the association between the −31G>C polymorphism in the promoter of survivin gene and the susceptibility to sporadic colorectal cancer (CRC) in a Southern Chinese population. Materials and

Methods:

The study was carried out on 711 healthy controls and 702 CRC cases of a Southern Chinese population. Survivin gene −31G>C genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism. The association between CRC risk and −31G>C genetic polymorphism was estimated using an unconditional logistic regression model.

Results:

The number of CC genotype carried in CRC patients was much higher than those of controls (P < 0.001). Compared with CC genotypes, GC, GG genotypes and −31G wild-type genotypes (i.e., GC + GG) had a significantly decreased risk of CRC (P < 0.001). In addition, survivin −31G wild-type genotypes were not associated with decreased risk of sporadic CRC patients with body mass index (BMI) ≥28.0 kg/m2, family cancer history, and premenopausal.

Conclusion:

Survivin −31G>C polymorphism is associated with sporadic CRC risk in the Southern Chinese population. The −31G wild-type genotypes and GC, GG genotypes are the independent protective factors against sporadic CRC excluding those with a BMI ≥28.0 kg/m2, family cancer history, and premenopausal

Full text: Available Index: IMSEAR (South-East Asia) Type of study: Observational study / Prognostic study / Risk factors Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Type of study: Observational study / Prognostic study / Risk factors Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2019 Type: Article